Inactive Instrument

Antares Stock

Equities

ANT

BE0003676872

Diversified Investment Services

Dynamic Chart
Antares Pharma Posts Higher Q4 Adjusted Earnings, Revenue; Issues 2022 Revenue Guidance MT
Earnings Flash (ATRS) ANTARES PHARMA Reports Q4 Revenue $48.7M, vs. Street Est of $47.2M MT
Earnings Flash (ATRS) ANTARES PHARMA Posts Q4 EPS $0.02, vs. Street Est of $0.01 MT
North American Morning Briefing : Oil Prices Top -3- DJ
Immo-Antares NV Reports Earnings Results for the Full Year Ended November 10, 2021 CI
Antares Vision Closes Acquisition Of US Software Firm ACSIS MT
Antares Pharma's New Drug Application Resubmission for Testosterone Replacement Therapy Receives FDA Acceptance MT
Antares Pharma Secures FDA Fast Track Designation for ATRS-1902 in Acute Adrenal Insufficiency MT
Antares Gets FDA Fast-Track Designation for ATRS-1902 for Adrenal Crisis Rescue DJ
Antares Pharma Says its Early-Stage Study of ATRS-1902 for Acute Adrenal Insufficiency Met its Primary Objective MT
Assertio Therapeutics Acquires Otrexup from Antares Pharma for $44 Million MT
Exclusive-Canada's CPP Investments seeks to sell insurance groups in strategy U-turn -sources RE
Antares Pharma Q3 Earnings Steady as Revenue Rises; Narrows Full-Year Sales Guidance -- Stock Drops MT
Earnings Flash (ATRS) ANTARES PHARMA Posts Q3 Revenue $48.2M, vs. Street Est of $47.9M MT
Lipocine : Signs Deal with Antares Pharma for Commercialization of Tlando in the US; Shares Rise Pre-Bell MT
More news
Antares is a real estate certificate issued by the company Immo-Antares. The activity of the company Immo-Antares consists in issuing certificates that gives the right to a quota of the distributions and determined property deals income. Real estate certificates are mainly offered to investors through a bid and are listed on the Brussels Euronext Regulated Market. Some are offered through a private offer. Immo-Antares issues real estate certificates that are admitted to trading on the Brussels Euronext Regulated Market, being specified that the shares constituting the capital of the company Le Patrimoine Immobilier are neither offered to the public nor, a fortiori, admitted to trading on a regulated market.
More about the company